InspireMD (NSPR) Common Equity (2010 - 2025)

InspireMD's Common Equity history runs 16 years deep, the most recent figure standing at $55.2 million for Q4 2025.

• On a quarterly basis, Common Equity rose 52.97% year-over-year to $55.2 million in Q4 2025; TTM through Dec 2025 was $55.2 million, a 52.97% increase from a year earlier, with the FY2025 full-year figure at $55.2 million, up 52.97% from the prior year.
• Common Equity slipped to $55.2 million in Q4 2025 per NSPR's latest filing, from $64.1 million in the prior quarter.
• Across five years, Common Equity topped out at $64.1 million in Q3 2025 and bottomed at $13.4 million in Q1 2023.
• The 5-year median for Common Equity is $36.6 million (2021), against an average of $36.0 million.
• Across the five-year window, Common Equity jumped 1164.14% in 2021 and slumped 56.71% in 2025, its largest moves.
• Year by year, Common Equity stood at $33.5 million in 2021, then sank by 48.13% to $17.4 million in 2022, then jumped by 127.11% to $39.5 million in 2023, then fell by 8.65% to $36.1 million in 2024, then soared by 52.97% to $55.2 million in 2025.
• Per Business Quant, the three latest NSPR Common Equity figures stand at $55.2 million (Q4 2025), $64.1 million (Q3 2025), and $20.2 million (Q2 2025).